Alessandro Isidori

4.8k total citations
89 papers, 2.4k citations indexed

About

Alessandro Isidori is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Alessandro Isidori has authored 89 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 29 papers in Genetics and 26 papers in Oncology. Recurrent topics in Alessandro Isidori's work include Acute Myeloid Leukemia Research (40 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Lymphoma Diagnosis and Treatment (17 papers). Alessandro Isidori is often cited by papers focused on Acute Myeloid Leukemia Research (40 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Lymphoma Diagnosis and Treatment (17 papers). Alessandro Isidori collaborates with scholars based in Italy, United States and United Kingdom. Alessandro Isidori's co-authors include Giuseppe Visani, Antonio Curti, Michele Baccarani, Roberto M. Lemoli, Federica Loscocco, Giovanni Martinelli, Pier Paolo Piccaluga, Mario P. Colombo, Michela Aluigi and Elisa Ferri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Alessandro Isidori

87 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Isidori Italy 26 1.1k 769 743 626 473 89 2.4k
Merav Leiba Israel 23 929 0.8× 930 1.2× 586 0.8× 824 1.3× 224 0.5× 77 2.0k
Michael Steurer Austria 27 615 0.5× 745 1.0× 799 1.1× 885 1.4× 663 1.4× 103 2.7k
Maria Christina Cox Italy 30 1.2k 1.1× 842 1.1× 430 0.6× 850 1.4× 516 1.1× 111 2.8k
Mathias Schmid Germany 24 807 0.7× 383 0.5× 233 0.3× 704 1.1× 638 1.3× 86 2.0k
Yoriaki Kaneko Japan 26 362 0.3× 290 0.4× 1.3k 1.8× 529 0.8× 138 0.3× 91 2.6k
Philippe Schafhausen Germany 22 583 0.5× 555 0.7× 171 0.2× 951 1.5× 643 1.4× 70 2.0k
Lei Gao China 25 667 0.6× 986 1.3× 562 0.8× 711 1.1× 467 1.0× 170 2.4k
George E. Georges United States 29 1.7k 1.5× 585 0.8× 777 1.0× 597 1.0× 641 1.4× 106 3.1k
Nobuhiro Takagi Japan 13 388 0.3× 449 0.6× 534 0.7× 259 0.4× 133 0.3× 21 1.7k
Tushar D. Bhagat United States 24 410 0.4× 452 0.6× 438 0.6× 1.5k 2.4× 210 0.4× 55 2.4k

Countries citing papers authored by Alessandro Isidori

Since Specialization
Citations

This map shows the geographic impact of Alessandro Isidori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Isidori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Isidori more than expected).

Fields of papers citing papers by Alessandro Isidori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Isidori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Isidori. The network helps show where Alessandro Isidori may publish in the future.

Co-authorship network of co-authors of Alessandro Isidori

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Isidori. A scholar is included among the top collaborators of Alessandro Isidori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Isidori. Alessandro Isidori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baratè, Claudia, Ilaria Scortechini, Federica Loscocco, et al.. (2024). Management of infections for patient treated with ibrutinib in clinical practice. Frontiers in Oncology. 14. 1428464–1428464.
2.
Visani, Giuseppe, Maryam Etebari, Fabio Fuligni, et al.. (2023). Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. Cancers. 15(6). 1785–1785. 1 indexed citations
3.
4.
Cerchione, Claudio, Alessandra Romano, Naval Daver, et al.. (2021). IDH1/IDH2 Inhibition in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 38 indexed citations
5.
Samra, Bachar, Marina Konopleva, Alessandro Isidori, Naval Daver, & Courtney D. DiNardo. (2020). Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions. Frontiers in Oncology. 10. 562558–562558. 47 indexed citations
6.
Isidori, Alessandro, Lorenza Borin, Elena Maria Elli, et al.. (2018). Iron toxicity – Its effect on the bone marrow. Blood Reviews. 32(6). 473–479. 43 indexed citations
7.
Tripodo, Claudio, Alessia Burocchi, Pier Paolo Piccaluga, et al.. (2017). Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. Cancer Research. 77(13). 3685–3699. 28 indexed citations
9.
Visani, Giuseppe, et al.. (2017). Deferasirox Boosts Hematopoietic Recovery after ALLO-Sct. Blood. 130. 5463–5463. 2 indexed citations
10.
Isidori, Alessandro, Federica Loscocco, Marilena Ciciarello, et al.. (2016). Renewing the immunological approach to AML treatment: from novel pathways to innovative therapies. 2(2). 226–251. 2 indexed citations
11.
Isidori, Alessandro, Valentina Salvestrini, Marilena Ciciarello, et al.. (2014). The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. Expert Review of Hematology. 7(6). 807–818. 60 indexed citations
12.
Tosi, Patrizia, Manuela Imola, Annalia Molinari, et al.. (2012). UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012069–e2012069. 1 indexed citations
13.
Visani, Giuseppe, et al.. (2012). AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012075–e2012075. 3 indexed citations
15.
Curti, Antonio, Simona Pandolfi, Michela Aluigi, et al.. (2005). Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. Experimental Hematology. 33(12). 1521–1530. 27 indexed citations
16.
17.
Visani, Giuseppe, Roberto M. Lemoli, Alessandro Isidori, et al.. (2001). Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients. Bone Marrow Transplantation. 27(8). 829–835. 6 indexed citations
18.
Visani, Giuseppe, Luigi Gugliotta, Patrizia Tosi, et al.. (2000). All‐trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia. European Journal Of Haematology. 64(3). 139–144. 20 indexed citations
19.
Visani, Giuseppe, Roberto M. Lemoli, Patrizia Tosi, et al.. (1999). Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Bone Marrow Transplantation. 24(5). 467–472. 42 indexed citations
20.
Visani, Giuseppe, Emanuela Ottaviani, Giorgio Zauli, et al.. (1999). All‐trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines. European Journal Of Haematology. 63(3). 149–153. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026